PA 824

From Wikipedia, the free encyclopedia

PA 824
IUPAC name (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-
6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
Identifiers
CAS number [187235-37-6]
PubChem 456199
MeSH PA+824
Properties
Molecular formula C14H12F3N3O5
Molar mass 359.258 g/mol
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)
Infobox disclaimer and references

PA 824 is an experimental anti-tuberculosis drug.[1]

[edit] References

  1. ^ Stover CK, Warrener P, VanDevanter DR, et al (2000). "A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis". Nature 405 (6789): 962–6. doi:10.1038/35016103. PMID 10879539. 

[edit] See also

Tablets  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.